Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Announces Appointment of Ricardo Zayas as Senior Vice President of Operations
June 24th, 2009
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on treating iron deficiency anemia and developing novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, announced that Ricardo Zayas has been appointed Senior Vice President of Operations. Mr. Zayas brings over two decades of pharmaceutical operations and commercial manufacturing experience to the Company. In his new position with AMAG, Mr. Zayas will be responsible for leading the Company's manufacturing, materials management, quality assurance, quality control, and supply chain functions and will report directly to Brian J.G. Pereira, MD, President and CEO. ...
Source: Vaccine Weekly (2009-06-24)
|
